BTSG · BrightSpring Health Services, Inc. · Documents

$71.21 -0.24 (-0.34%) At close · Nov 13 Play latest call Q3 2026 earnings call transcript

S&P 400 member Russell 2000 member Rebalance outlook locked

Market Cap

$14.17B

198.98M

Volume · Nov 13 1.35M Avg daily vol (3M) 2.42M

The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →

Annual report FY2025 Revenue $12.91B up 28.2% 10-K filed Feb 27, 2026 Quarterly report FY2026 Q3 Revenue $4.21B up 26.4% 10-Q filed Oct 30, 2026 Latest results Financial results 8-K filed Oct 30, 2026 Earnings call Q3 2026 earnings call Held Oct 30, 2026

2026

Oct 30

Earnings call

Revenue rises 26%, adjusted EBITDA rises 42%

BrightSpring reported third-quarter revenue of $4.2 billion, up 26% year-over-year, and adjusted EBITDA of $228 million, up 42%. Full-year 2026 guidance calls for revenue of $15.9 to $16.125 billion and adjusted EBITDA of $850 to $860 million.

Read from the first part of this long document

5 source passages

My name is David Dykler with Investor Relations at BrightSpring. For the third quarter of 2026, company revenue was $4.2 billion, representing 26% growth from the prior year period. Adjusted EBITDA for the total company was $228 million in the third quarter, an increase of 42% compared to the third quarter of 2025. Total revenue is expected to be in the range of $15.9 to $16.125 billion, including pharmacy solutions revenue of $14.0 to $14.2 billion and provider services revenue of $1.9 to $1.925 billion. Total adjusted EBITDA is now expected to be in the range of $850 to $860 million for the full year 2026. Open the document at this passage

Oct 30

Quarterly report 10-Q FY2026 Q3, ended Sep 30

Revenue rises 26.4% as Adjusted EBITDA reaches $227.8 million

BrightSpring reported third-quarter revenue of $4.2 billion, up 26.4%, and Adjusted EBITDA of $227.8 million, up 42.0%. Net income from continuing operations increased $63.3 million to $100.8 million.

Revenue $4.21B ▲ 26.4% Net income $100.14M ▲ 79.3% Diluted EPS $0.45 ▲ 73.1%

Read from the MD&A section

4 source passages

Consolidated BrightSpring Revenue grew by $879.1 million, or 26.4%, to $4.2 billion Adjusted EBITDA(1) increased by $67.3 million, or 42.0%, to $227.8 million Net income from continuing operations increased by $63.3 million to $100.8 million Open the document at this passage

Oct 30

Current report 8-K

Financial results

BrightSpring Health Services, Inc. reported third-quarter net revenue of $4,213 million and Adjusted EBITDA of $228 million, and raised full year 2026 Revenue guidance to $15,900 million to $16,125 million and Adjusted EBITDA guidance to $850 million to $860 million.

Sep 15

Investor event

Morgan Stanley 24th Annual Global Healthcare Conference AI summary on its way

Sep 14

Investor event

2026 Jefferies Healthcare Services and Technology Conference AI summary on its way

Sep 10

Investor event

Wells Fargo 21st Annual Healthcare Conference AI summary on its way

Jul 31

Earnings call

Q2 2026 earnings call AI summary on its way